A Dedicated Healthcare Investment Syndicate

We invest at the early stage across women's health, frontier and biotech, and health financing, maintaining a global perspective with a strategic focus on Africa and other underserved markets.

Invest with us Founders, pitch us

About RaisewithSurf

RaisewithSurf is an early-stage healthcare investment syndicate focused on backing founders solving healthcare's most consequential challenges across women's health, frontier and biotech, and health financing.

Capital is deployed on a deal-by-deal basis through Special Purpose Vehicles, bringing together institutional investors, capital partners, healthcare operators, industry professionals, ecosystem partners, and emerging investors around each investment opportunity.

Our objective is not simply to identify promising companies, but to invest in businesses capable of delivering measurable improvements in patient outcomes while building enduring enterprise value.

One continuous argument

Our thesis is not a list of sectors. It is a chain, where each conviction answers the failure the last one exposes.

Women's health has been structurally overlooked

A long-standing deficit in dedicated R&D, a scarcity of specialised diagnostics, and few solutions designed for female physiology have led to adverse outcomes and premature mortality that targeted investment could prevent.

The hardest problems are scientific problems

The gap between what medicine can do and what patients receive will not close through incremental innovation, but through scientific breakthroughs in how disease is detected, treated, and managed.

Yet the scientific foundation is underbuilt

Across underserved and emerging markets, the research infrastructure, biotechnology ecosystems, and clinical trial networks that underpin modern healthcare are still in their infancy. Building them is one of the largest opportunities of the coming decades.

Innovation only matters if it reaches people

Breakthroughs create little impact if they remain inaccessible or unaffordable. Financing is not a payment mechanism but a foundational component of care, determining who receives it and when.

Investment Verticals

Women's Health

Prioritizing the diagnosis, care, and treatment of conditions that disproportionately affect women

1.2M

women killed each year by gynecological cancers worldwide

94%

of cervical cancer deaths, a preventable disease, occur in low- and middle-income countries

~2%

of healthcare venture funding reaches women's health

These outcomes are not solely the consequence of biological complexity, but of persistent gaps in scientific innovation, early detection, and access to care. As recently as 2020, only 5% of global health R&D was directed toward women's health, and of that, just 1% reached the wide range of conditions beyond women's cancers. We back founders building the future of women's health across every stage of a woman's life, advancing the science, technologies, and models of care that will define the next generation of healthcare for women.

DiagnosticsPrecision medicine in women's healthWearable technologiesMaternal healthNew models of care

Investment Verticals

Frontier and Biotech

Investing at the convergence of science and technology

Breakthroughs in biotechnology and frontier technologies are reshaping what is scientifically and commercially possible. We are drawn to the deployable edge of frontier science, the innovations that reach patients on a realistic commercial horizon.

$5T+

projected global biotechnology industry by the early 2030s

$39B to $500B

projected growth of the global AI-in-healthcare market over the next decade

We invest in founders turning scientific breakthroughs into products that can be clinically validated, commercially adopted, and delivered at scale.

Advanced diagnosticsGenomicsPrecision medicineClinical AIPoint-of-care innovationMedical technologies

Investment Verticals

Health Financing

Making care something people can afford

Across underserved and emerging markets, the greatest barrier to healthcare is often not the absence of treatment, but the inability to pay for it. We view financing not as a supporting function but as a core component of the healthcare system itself.

Coverage

Insurance and micro-health products that extend financial protection to underserved populations.

Credit

Platforms that let patients spread the cost of treatment and avoid catastrophic expenditure.

Savings

Solutions that help individuals prepare financially for future healthcare needs.

Investment Criteria

Every company is measured against six standards before we invest.

Clinical Validation

A significant unmet clinical need and a credible pathway to improving patient outcomes, supported by evidence appropriate to the company's stage.

Commercial Validation

Evidence the market has validated the problem: early revenue, adoption, pilot conversions, repeat usage, or strategic partnerships.

Business Model

A commercially viable model with sound unit economics, capital efficiency, and the ability to deploy capital toward durable growth.

Founder Quality

Deep domain expertise, execution capability, founder-market fit, and integrity, capable of building enduring institutions.

Scalability

A credible pathway to venture-scale outcomes and the potential to build defensible advantages over time.

Regulatory Readiness

Preparedness to operate within the legal and clinical frameworks of its target markets.

Investment Strategy

Stage

Early stage, partnering with founders when strategic support and long-term alignment can most influence the business.

Geography

Thesis-driven, not geography-constrained. A strategic emphasis on Africa and other underserved markets.

Structure

Deal-by-deal SPVs, combining institutional underwriting with the flexibility of syndicate investing.

Focus

Category-defining companies across our three core verticals.

Investment Process

Sourcing and Screening

Proprietary dealflow through long-standing relationships with founders, investors, accelerators, and ecosystem partners. Every opportunity is evaluated against a consistent set of criteria.

Due Diligence

Institutional-grade review across financial, legal, regulatory, and commercial analysis, with a complete memo for every deal.

Syndication and Close

The opportunity opens to our network, commitments are pooled into a purpose-built SPV, and capital is transferred with full transparency.

Portfolio Support

Active post-investment support: strategic advisory, legal guidance, network introductions, and ongoing counsel.

Team

Built from conviction

Abisayo Olawuyi

Founder & Managing Partner

A venture capital practitioner and lawyer with over a decade of experience at the intersection of healthcare, technology, law, and finance. She has advised founders and investors across venture financings, structured early-stage transactions, and supported companies through investment readiness and capital formation. Raised in a family with deep roots in pharmacy and insurance, she developed an early understanding of how healthcare systems are financed, delivered, and where they systematically fail. RaisewithSurf was established to direct dedicated capital toward founders building solutions to healthcare's most urgent and persistently underfunded challenges.

Strategic Advisors

Kizito Okorowu

Venture Advisor

Early-stage venture advisor with over eight years helping founders bring ideas to market with clarity, structure, and operational discipline. A venture judge and mentor with Silverspoon Angels, UK-Nigeria Tech Hub, Co-Creation Hub, and TechMITAfrica. Fellow at Dream VC and the New England Impact Investing Initiative.

Alfons Porro i Martorell

Strategic Advisor

Healthcare and impact investor with deep expertise in strategy, corporate development, and investment. Alfons brings a rigorous European institutional perspective on deal evaluation, portfolio strategy, and the global impact capital landscape.

Partner with us

RaisewithSurf is actively building a community of aligned partners directing conviction capital toward the most urgent healthcare innovation across Africa and other underserved markets.

Operators & Emerging Investors

Clinicians, hospital administrators, and healthcare professionals; African professionals globally with continent-level conviction; and first-time investors and micro-VCs building exposure to these markets.

LP & Capital Partners

Development finance institutions, impact foundations, corporate venture arms, angels, and family offices deploying into African healthtech through a dedicated, locally grounded vehicle with institutional-grade sourcing and diligence.

Strategic & Ecosystem Partners

Healthcare corporates, insurers, pharmaceutical companies, and ecosystem organizations seeking early strategic positioning as co-investors, commercial partners, or ecosystem supporters.

Participation starts at $2,000 per deal. Above that there is no fixed ceiling: allocations range from small to large individual commitments through to institutional participation, sized against each round and agreed per opportunity.

Get in touch